BACKGROUND: There are currently limited data regarding the prevalence of antimicrobial-resistant organisms causing community-acquired urinary tract infections among adult women in Canada. Trimethoprim-sulfamethoxazole (TMP-SMX) is the recommended first-line empirical antibiotic treatment, unless resistance of Escherichia coli to TMP-SMX exceeds 20%. OBJECTIVE: To assess current levels of TMP-SMX-resistant E coli in community-acquired cases of urinary tract infection in adult women. METHOD: Assessment of urine culture reports obtained from 21 laboratories across Canada, submitted by family physicians for women aged 16 years and older. RESULTS: In 2199 adult women with a positive urine culture, 1079 (49.1%) of pathogens isolated were resistant to at least one antibiotic and 660 (30.0%) were multidrug-resistant (resistant to two or more antibiotics). TMP-SMX resistance was seen in 245 of 1613 (15.2%) E coli isolates (95% CI 13.5 to 17.0). This proportion was higher in women 50 years of age and older (155 of 863 isolates [18.0%]; P=0.001), in British Columbia (70 of 342 isolates [20.5%]) and in Ontario (62 of 370 isolates [16.8%]) when compared with eastern provinces (65 of 572 isolates [11.4%]; P=0.001). Fluoroquinolone-resistant E coli occurred in 107 of 1557 (6.9%) isolates (95% CI 5.7 to 8.2), with the highest level found in British Columbia (54 of 341 isolates [15.8%]; P=0.001). CONCLUSION: TMP-SMX continues to be appropriate as first-line empirical treatment of acute cystitis in adult women in Canada, as resistance remains below 20%. However, TMP-SMX resistance is higher in older women and in some provinces. The level of fluoroquinolone-resistant E coli is highest in British Columbia.
BACKGROUND: There are currently limited data regarding the prevalence of antimicrobial-resistant organisms causing community-acquired urinary tract infections among adult women in Canada. Trimethoprim-sulfamethoxazole (TMP-SMX) is the recommended first-line empirical antibiotic treatment, unless resistance of Escherichia coli to TMP-SMX exceeds 20%. OBJECTIVE: To assess current levels of TMP-SMX-resistant E coli in community-acquired cases of urinary tract infection in adult women. METHOD: Assessment of urine culture reports obtained from 21 laboratories across Canada, submitted by family physicians for women aged 16 years and older. RESULTS: In 2199 adult women with a positive urine culture, 1079 (49.1%) of pathogens isolated were resistant to at least one antibiotic and 660 (30.0%) were multidrug-resistant (resistant to two or more antibiotics). TMP-SMX resistance was seen in 245 of 1613 (15.2%) E coli isolates (95% CI 13.5 to 17.0). This proportion was higher in women 50 years of age and older (155 of 863 isolates [18.0%]; P=0.001), in British Columbia (70 of 342 isolates [20.5%]) and in Ontario (62 of 370 isolates [16.8%]) when compared with eastern provinces (65 of 572 isolates [11.4%]; P=0.001). Fluoroquinolone-resistant E coli occurred in 107 of 1557 (6.9%) isolates (95% CI 5.7 to 8.2), with the highest level found in British Columbia (54 of 341 isolates [15.8%]; P=0.001). CONCLUSION:TMP-SMX continues to be appropriate as first-line empirical treatment of acute cystitis in adult women in Canada, as resistance remains below 20%. However, TMP-SMX resistance is higher in older women and in some provinces. The level of fluoroquinolone-resistant E coli is highest in British Columbia.
Authors: David M Patrick; Fawziah Marra; James Hutchinson; Dominique L Monnet; Helen Ng; William R Bowie Journal: Clin Infect Dis Date: 2004-06-01 Impact factor: 9.079
Authors: Thomas M Hooton; Richard Besser; Betsy Foxman; Thomas R Fritsche; Lindsay E Nicolle Journal: Clin Infect Dis Date: 2004-06-14 Impact factor: 9.079
Authors: G G Zhanel; J A Karlowsky; G K Harding; A Carrie; T Mazzulli; D E Low; D J Hoban Journal: Antimicrob Agents Chemother Date: 2000-04 Impact factor: 5.191
Authors: Derelie A Richards; Les J Toop; Stephen T Chambers; Margaret G Sutherland; Ben H Harris; Rosemary B Ikram; Mark R Jones; Graham R B McGeoch; Barbara Peddie Journal: N Z Med J Date: 2002-01-25
Authors: Warren J McIsaac; Tony Mazzulli; Rahim Moineddin; Janet Raboud; Susan Ross Journal: Can J Infect Dis Med Microbiol Date: 2004-09 Impact factor: 2.471
Authors: Namisha Singh; Sonja Gandhi; Eric McArthur; Louise Moist; Arsh K Jain; Aiden R Liu; Manish M Sood; Amit X Garg Journal: CMAJ Date: 2015-04-27 Impact factor: 8.262
Authors: Louise Perrault; Sybil Dahan; Ange Christelle Iliza; Jacques LeLorier; George G Zhanel Journal: Can J Infect Dis Med Microbiol Date: 2017-02-20 Impact factor: 2.471